Patent intelligence · US
US 2012259187
DYNAMIC COLORECTAL PDT APPLICATION
DYNAMIC COLORECTAL PDT APPLICATION
Patent details — US 2012259187
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 11, 2012
- Expiration
- Oct 6, 2032
- Applicant
- KRUIJT BASTIAAN [NL]
- CPC classes
- A61K 31/ 409 A I, A61K/31409, A61P 35/ 00 A I, A61P/3500
Quick answer
US 2012259187 (DYNAMIC COLORECTAL PDT APPLICATION) is held by KRUIJT BASTIAAN [NL]. Status: granted. Granted Oct 11, 2012. Expires Oct 6, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- KRUIJT BASTIAAN [NL]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 409 A I, A61K/31409, A61P 35/ 00 A I, A61P/3500
More from KRUIJT BASTIAAN [NL]
Related pharmaceutical patents in our USPTO index.
-
BR PI0714667
conjugado molecular e respectivo uso
granted -
MX 2013000877
APPLICATION OF β-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT.
granted -
US 2013041307
APPLICATION OF BETA-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT
granted -
WO 2013015774
DIHYDROXY-CHLORINES GLYCO-SUBSTITUÉES ET CHLORINES BÊTA-FONCTIONNALISÉES POUR THÉRAPIE ANTIMICROBIENNE PHOTODYNAMIQUE
granted -
BR PI0614453
método de redução de cululite indesejada em áreas seletivas de um organismo e mistura fotossensibilizante
granted -
US 2012263625
GLYCO-SUBSTITUTED DIHYDROXY-CHLORINS AND ß-FUNCTIONALIZED CHLORINS FOR ANTI-MICROBIAL PHOTODYNAMIC THERAPY
granted -
US 2011206613
METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT
granted
Frequently asked questions
What is US patent 2012259187?
US 2012259187 (DYNAMIC COLORECTAL PDT APPLICATION) is held by KRUIJT BASTIAAN [NL]. Status: granted. Granted Oct 11, 2012. Expires Oct 6, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 2012259187?
KRUIJT BASTIAAN [NL] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does US 2012259187 expire?
Our index shows an expiration date of Oct 6, 2032 (6 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.